Abdominal migraine should be considered a possible source of incurable abdominal pain in adults when accompanied by a complete gastrointestinal workup with normal results. We recommend a trial of topiramate as prophylactic therapy if abdominal migraine is the likely source of the pain.
Introduction: Limited guidance has been provided for opioid de-escalation when managing pain associated with vaso-occlusive crisis (VOC) in hospitalized patients with sickle cell disease (SCD). Therefore, a pain management protocol was developed for use in this population and piloted at a tertiary academic medical center.Objective: To assess implementation of a newly developed pain management protocol for use in hospitalized patients with a VOC.Methods: This was a retrospective, single-center, pre-post cohort study of SCD patients admitted with a VOC between June 1, 2018 to June 1, 2019 (pre-protocol) and December 31, 2019 to May 12, 2020 (post-protocol). The primary outcome was a reduction in intravenous (IV) short-acting opioid utilization as defined by the proportion of hospitalized days where the route of administration for short-acting opioids was oral rather than IV for ≥75% of doses given. Secondary outcomes included the proportion of hospitalized days where ≥50% and ≥25% of the short-acting opioid doses were administered by mouth. Opioid use (in morphine milligram equivalents [MME]) was also compared between groups.Results: A total of 96 admissions in the pre-protocol group and 29 admissions in the post-protocol group were included in the study. There was a statistically significant increase in the proportion of hospitalized days where ≥75% of the short-acting opioid doses were administered by mouth rather than IV in the post-protocol group compared with the pre-protocol group (0% vs 8.3%, P = .0114). Intravenous opioid use and total opioid use in the post-protocol group was lower compared with the pre-protocol group.
Conclusion:Implementation of a pain management protocol for use in hospitalized SCD patients admitted with VOC was associated with an increase in the use of oral short-acting opioids and reduced overall opioid use.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.